Metro Healthcare Indonesia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 106.3K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 30.2× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 106.3K). Which is the better fit depends on your goals.
| CARE | PRDL | |
|---|---|---|
Market Cap | 14.23T | 470.58B |
Volume | 106.3K | 28.43M |
Lot | 1.06K | 284.34K |
Turnover | 45.42M | 7.8B |
Average Price | 427.26 | 274.19 |
Value | 45.42M | 7.8B |
Indicative Equilibrium Price | 426 | 270 |
Indicative Equilibrium Volume | 25 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →